etizolam has been researched along with Recrudescence in 1 studies
etizolam: structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hematoma recurrence was not detected in the etizolam group 3 months after surgery, but occurred in the control group." | 2.70 | Etizolam, an anti-anxiety agent, attenuates recurrence of chronic subdural hematoma--evaluation by computed tomography. ( Endo, S; Hamada, H; Hayashi, N; Hirashima, Y; Kuwayama, N, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirashima, Y | 1 |
| Kuwayama, N | 1 |
| Hamada, H | 1 |
| Hayashi, N | 1 |
| Endo, S | 1 |
1 trial available for etizolam and Recrudescence
| Article | Year |
|---|---|
Etizolam, an anti-anxiety agent, attenuates recurrence of chronic subdural hematoma--evaluation by computed tomography.
Topics: Aged; Anti-Anxiety Agents; Diazepam; Female; Follow-Up Studies; Hematoma, Subdural, Chronic; Humans; | 2002 |